跳至主要内容
临床试验/NL-OMON34885
NL-OMON34885已完成不适用

Rising Single Dose Safety, Tolerability and Pharmacokinetic Study of SCH 900229 in Healthy Adult Subjects - SCH 900229 SAD study

Schering-Plough0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy men and women, between 30 and 65 years of age (inclusive), BMI between 18 and 30 kg/m2, no more cigarettes than 10 per day, female have been surgically sterilized for at least 3 months before screening or post-menopausal for at least one year.

排除标准

  • Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor (50 mL or more) within 60 days from the start of the study. In case of donating more than 1.5 liters of blood (for men) / more than 1.0 liters of blood (for women) in the 10 months preceding the start of this study.

研究者

发起方
Schering-Plough

相似试验